Where are we with surgical therapies for Parkinson's disease?

Parkinsonism and Related Disorders

Volumn 20, Issue SUPPL.1, 2014, Pages

  Strauss, Ido ^a   Kalia, Suneil K ^a   Lozano, Andres M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Deep brain stimulation; Parkinson's disease; Surgical therapies

Indexed keywords

CERE 120; GLUTAMATE DECARBOXYLASE; LEVODOPA; NEURTURIN; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL EFFECTIVENESS; DEEP VEIN THROMBOSIS; DYSKINESIA; ELECTRODE IMPLANT; GENERAL ANESTHESIA; MENTAL DETERIORATION; NEUROMODULATION; OPERATION DURATION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUBTHALAMIC NUCLEUS; SURGICAL RISK; VIRAL GENE THERAPY;

DEEP BRAIN STIMULATION; PARKINSON'S DISEASE; SURGICAL THERAPIES;

BRAIN; DEEP BRAIN STIMULATION; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE;

EID: 84887858392     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/S1353-8020(13)70044-0     Document Type: Article

References (30)

1. De Lau LML, Breteler MMB Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5:525-535.
2. Lang AE, Obeso JA Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004, 3:309-316.
3. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000, 342:1484-1491.
4. Sankar T, Lozano AM Surgical approach to L-dopa-induced dyskinesias. Int Rev Neurobiol 2011, 98:151-171.
5. Deep-Brain Stimulation for Parkinson's Disease Study Group Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001, 345:956-963.
6. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010, 25:578-586.
7. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006, 5:578-588.
8. Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009, 65:586-595.
9. Odekerken VJJ, van Laar T, Staal MJ, Mosch A, Hoffmann CFE, Nijssen PCG, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013, 12:37-44.
10. Broen M, Duits A, Visser-Vandewalle V, Temel Y, Winogrodzka A Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord 2011, 17:413-417.
11. Voon V, Krack P, Lang AE, Lozano AM, Dujardin K, Schüpbach M, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. J Neurol 2008, 131:2720-2728.
12. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010, 362:2077-2091.
13. Chaudhuri KR, Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006, 21:916-923.
14. Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008, 23:837-844.
15. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. J Neurol 2007, 130:1596-1607.
16. Uitti RJ Tandem deep brain stimulation - challenging new structural targets for Parkinson's disease. Parkinsonism Relat Disord 2012, 18(Suppl 1):S171-S173.
17. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
18. Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P Depression in Parkinson disease - epidemiology, mechanisms and management. Nat Rev Neurol 2012, 8:35-47.
19. Freund H-J, Kuhn J, Lenartz D, Mai JK, Schnell T, Klosterkoetter J, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 2009, 66:781-785.
20. Slavin KV, Thulborn KR, Wess C, Nersesyan H Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol 2006, 27:80-84.
21. Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg 2010, 112:479-490.
22. Burchiel KJ, McCartney S, Lee A, Raslan AM Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg 2013, 119:301-306.
23. Rosin B, Slovik M, Mitelman R, Rivlin-Etzion M, Haber SN, Israel Z, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011, 72:370-384.
24. Little S, Pogosyan A, Neal S, Zavala B, Zrinzo L, Hariz M, et al. Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol 2013, 74:449-457.
25. Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013, 369:640-648.
26. Lipsman N, Schwartz ML, Huang Y, Lee L, Sankar T, Chapman M, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol 2013, 12:462-468.
27. LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 2011, 10:309-319.
28. Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 2010, 9:1164-1172.
29. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001, 344:710-719.
30. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54:403-414.